Daraxonrasib shrinks tumours in one-third of lung cancer patients
Revolution Medicines Inc. (NASDAQ: RVMD) has reported encouraging lung cancer results for its experimental cancer pill daraxonrasib. The…
FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancer
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to…
Tiny organism offers insight into neurological side effects of chemotherapy
Chemotherapy remains one of the most powerful tools in the fight against cancer, yet it often comes with…
Study offers new models for studying causes of chemo brain
Cancer is a challenging enough diagnosis, but many patients are dealt a second blow, even as they heal:…